A series of novel thiopyrano [2,3-d] [1, 3] [2,3-d] [1, 3] [4',3':4,5] thiopyrano [2,3- [2,3-d] [1, 3] thiazoles, screening, antiviral activity. V iruses are known as common pathogens that cause a variety of diseases. Search for new efficient antiviral agents is an important worldwide problem among scientists and clinicians, because of rapid emergence of drug resistant strains. Even influenza virus may cause life-threatening events in high-risk patients. To overcome the drawbacks of the current antiviral drugs and to obtain more efficacious drugs, new antiviral drugs with a novel mode of action should be developed. Thiopyrano [2,3-d] [1, 3] thiazoles have become a promising area of research because of their diverse biological activities, such as anticancer, antitrypanosomal, antimycobacterial, anti-inflammatory and antioxidant 1-7 ( Fig. 1 ). In the last two decades, there has been an increase in the number of studies on 4-thiazolidinone derivatives as potential antiviral agents 8-13 . Thiopyrano [2,3-d] [1, 3] thiazoles could be of special interest as cyclic mimetics of biologically active (including antiviral) 4-thiazolidinones. The aim of present study was to estimate the antiviral activity of new thiopyrano [2,3-d] [1, 3] thiazole derivatives.
thiazoles, alkyl rel-(5R,5aR,11bS)-2,6-dioxo-3,5a,6,11b-tetrahydro-2Н,5H-chromeno

Materials and Methods
The synthesis of 2-oxo-3,7-dihydro-2Н-thiopyrano [2,3- (6) (7) (8) (9) (10) (11) (12) (13) 16 , 6-carboxymethylene-2-oxo-3,5,6,7-tetrahydro-2h-
3 and their characteristics were described in our previous reports. The structure of compounds involved in the study is presented in Fig. 2 .
The antiviral activity screening of the compounds was performed at the National Institute of 
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. Results for each tested compound were reported as virusinhibitory concentration; 50% endpoint (EC 50 ) and cell-inhibitory concentration, 50% endpoint (CC 50 ) were determined. A general selectivity index (SI) was calculated as a ration of (EC 50 )/(CC 50 ). An SI of 3 or greater indicates that confirmatory testing is needed.
Inhibition of Viral Cytopathic Effect (CPE).
This test, run in 96 well flat-bottomed microplates, was used for the initial antiviral evaluation of compounds. In this CPE inhibition test, four log10 dilutions of each test compound (e.g. 1000, 100, 10, 1 µg/ml) were added to 3 cups containing the cell monolayer; within 5 min. On the next step, the virus was added and the plate was sealed and incubated at 37°C. CPE read microscopically when untreated infected controls develop a 3 to 4+ CPE (approximately 72 to 120 hr). A known positive control drug Ribavirin was evaluated in parallel with test drugs in each test. The data are expressed as 50% effective concentrations (EC 50 ).
Increase in Neutral Red (NR) Dye uptake. This test was run to validate the CPE inhibition seen in the initial test, and utilized the same 96-well micro plates after the CPE has been read. When neutral red was added to the medium cells that were not damaged by virus take up a greater amount of dye, which is desplayed on a computerized microplate autoreader. An EC 50 was determined from this dye uptake.
cytotoxicity. In the CPE inhibition tests, two wells of uninfected cells treated with each concentration of tested compounds was run in parallel with the infected, treated wells. At the time CPE was determined microscopically. The toxicity control cells were also examined microscopically for any changes in cell appearance compared to normal control cells run in the same plate. These changes may be enlargement, granularity, cells with ragged edges, filmy appearance, rounding, detachment from the surface of the well, or other changes. These changes were given a designation of T (100% toxic), PVH (partially toxic-very heavy -80%), PH (partially toxic-heavy -60%), P (partially toxic -40%), Ps (partially toxic-slight-20%), or 0 (no toxicity -0%), conforming to the degree of cytotoxicity seen. A 50% cell inhibitory (cytotoxic) concentration (CC 50 ) was determined by regression analysis of these data.
results and discussions
Antiviral activity assay of synthesized compounds allowed us to identify some highly active thiopyrano [2,3- Table. A -(5R,5aR,11bs) contributes for antiviral activity increasing (Fig. 3) . Moreover, two the most active hits 8 and 11 belong to the above-mentioned group of thiopyrano [2,3- 
